21 C.F.R. § 862.1565

6-Phosphogluconate dehydrogenase test system.

Last amended: 2016Year: 2026Length: 98 wordsSubsections: 1Official source

Cite as 21 C.F.R. § 862.1565 (2026)

(a) Identification. A 6-phosphogluconate dehydrogenase test system is a device intended to measure the activity of the enzyme 6-phosphogluconate dehydrogenase (6 PGD) in serum and erythrocytes. Measurements of 6-phosphogluconate dehydrogenase are used in the diagnosis and treatment of certain liver diseases (such as hepatitis) and anemias. (b) Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9. [52 FR 16122, May 1, 1987, as amended at 53 FR 21449, June 8, 1988; 66 FR 38788, July 25, 2001]
Cross-references to the CFR
862.9.
21 C.F.R. § 862.1565: 6-Phosphogluconate dehydrogenase test system. | Justis AI